Open Access<p>Doxorubicin Delivered Using Nanoparticles Camouflaged with Mesenchymal Stem Cell Membranes to Treat Colon Cancer</p>
Author(s) -
Yi Liu,
Jingtong Zhao,
Jinlan Jiang,
Fangfang Chen,
Xuedong Fang
Publication year - 2020
Publication title -
international journal of nanomedicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.245
H-Index - 128
eISSN - 1178-2013
pISSN - 1176-9114
DOI - 10.2147/ijn.s242787
Subject(s) - mesenchymal stem cell , doxorubicin , in vivo , chemistry , flow cytometry , nanocarriers , cytotoxicity , drug delivery , biophysics , cancer research , in vitro , materials science , pharmacology , microbiology and biotechnology , pathology , medicine , chemotherapy , nanotechnology , biology , biochemistry , surgery
The primary goal of the present study was to design doxorubicin (DOX)-loaded superparamagnetic iron oxide (SPIO) nanoparticles (NPs) coated with mesenchymal stem cell (MSC) membranes and explore their effect on colon cancer in vitro and in vivo.